trihexyphenidyl has been researched along with Lewy Body Disease in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, K | 1 |
| Wada, I | 1 |
| Okunomiya, T | 1 |
| Shima, A | 1 |
| Kambe, D | 1 |
| Shinde, A | 1 |
| Kageyama, T | 1 |
| Suenaga, T | 1 |
1 other study available for trihexyphenidyl and Lewy Body Disease
| Article | Year |
|---|---|
Dropped head syndrome preceding the onset of dementia with Lewy bodies.
Topics: Aged; Brain; Cholinergic Antagonists; Female; Humans; Iofetamine; Lewy Body Disease; Magnetic Resona | 2014 |